IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-01482660.html
   My bibliography  Save this paper

Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis

Author

Listed:
  • Alexandre Decourt
  • Bertrand Gondouin

    (VRCM - Vascular research center of Marseille - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale)

  • Jean Christophe Delaroziere

    (Service de Chirurgie et Radiologie Pédiatrique - Université de la Méditerranée - Aix-Marseille 2)

  • Philippe Brunet

    (VRCM - Vascular research center of Marseille - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale)

  • Marion Sallée

    (VRCM - Vascular research center of Marseille - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale)

  • Stéphane Burtey

    (Chirurgie urologique et transplantation rénale [Hôpital de la Conception - APHM] - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille - LA CONCEPTION - Hôpital de la Conception [CHU - APHM], VRCM - Vascular research center of Marseille - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale)

  • Bertrand Dussol

    (Chirurgie urologique et transplantation rénale [Hôpital de la Conception - APHM] - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille - LA CONCEPTION - Hôpital de la Conception [CHU - APHM], VRCM - Vascular research center of Marseille - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale)

  • Vadim Ivanov

    (Service d’hématologie et de thérapie cellulaire - LA CONCEPTION - Hôpital de la Conception [CHU - APHM])

  • Régis Costello

    (TAGC - Technologies avancées pour le génôme et la clinique - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique)

  • Cecile Couchoud

    (Registre REIN - Agence de la biomédecine [Saint-Denis la Plaine])

  • Noemie Jourde-Chiche

    (VRCM - Vascular research center of Marseille - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale, Physiopathologie de l'Endothelium - VRCM - Vascular research center of Marseille - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale, LA CONCEPTION - Hôpital de la Conception [CHU - APHM])

Abstract

Monoclonal gammopathies (MGs) with renal involvement can lead to ESRD caused by myeloma cast nephropathy (MCN), immunoglobulin light chain amyloidosis (ALA), or light-chain deposition disease (LCDD). Few studies have focused on the prognosis of patients with MG on chronic dialysis. We evaluated the outcomes of patients with MG incident on chronic dialysis in France. All incident patients registered in the Renal Epidemiology and Information Network Registry between 2002 and 2011 with ESRD caused by ALA, LCDD, or MCN were included. Patient's survival, censored for renal transplantation, renal recovery, and loss to follow-up, as well as renal outcomes were analyzed and compared with a control group. Risk factors and causes of death were analyzed. We included 1459 patients, comprising 265 (18%) patients with ALA, 334 (23%) patients with LCDD, and 861 (59%) patients with MCN. Median age was 72 years, and 56% were men. Median follow-up was 13.1 months. Renal recovery was observed in 9.1% of patients and more frequent after 2006. Kidney transplantation was rare in this population (2.3%). Among 1272 patients who remained on dialysis, 67% died. Median survival on dialysis was 18.3 months. Main causes of death were malignancies (34.4%), cardiovascular diseases (18%), infections (13.3%), and cachexia (5.2%). Independent risk factors of death were age (hazard ratio [HR], 1.03 per year increase; 95% confidence interval [95% CI], 1.02 to 1.03), frailty (HR, 1.93; 95% CI, 1.58 to 2.36), congestive heart failure (HR, 1.54; 95% CI, 1.23 to 1.93), and dialysis initiation on a central catheter (HR, 1.40; 95% CI, 1.11 to 1.75). Factors associated with a lower risk of death were year of dialysis initiation (HR, 0.95 per year increase; 95% CI, 0.91 to 0.99) and high BP (HR, 0.80; 95% CI, 0.67 to 0.97). Survival of patients with ALA, LCDD, or MCN on chronic dialysis is poor but has improved over time. Progressive malignancy is the main cause of death in this population. Renal recovery has increased since 2006.

Suggested Citation

  • Alexandre Decourt & Bertrand Gondouin & Jean Christophe Delaroziere & Philippe Brunet & Marion Sallée & Stéphane Burtey & Bertrand Dussol & Vadim Ivanov & Régis Costello & Cecile Couchoud & Noemie Jou, 2016. "Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis," Post-Print hal-01482660, HAL.
    • Handle: RePEc:hal:journl:hal-01482660
    DOI: 10.2215/CJN.06290615
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-01482660. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.